Clinical Trial Update: Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone [NA]

View source ↗

Summary

A completed clinical trial evaluated diabetes risk factors in people with schizophrenia or bipolar disorder after switching to ziprasidone; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2012-11-19